ClinicalTrials.gov
public full text
Public Domain
ImPROving Quality of LIFe in the Long COVID Patient
The purpose of this study is to investigate the efficacy of orally administered nirmatrelvir/ritonavir compared with placebo/ritonavir to improve quality of life in non-hospitalized adult participants suffering from post-acute COVID-19 syndrome.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Real World COVID-19 Antiviral Effectiveness Research#830601
- Oral nirmatrelvir-ritonavir for COVID-19 in higher risk outpatients#298976
- Effectiveness and Safety of New Oral Antivirals for COVID-19#1046396
- Clinical Study in the Treatment of Patients With COVID-19#884560
- A Study to Compare S-217622 With Placebo in Non-Hospitalized Participants With COVID-19#847382
Record · ID 1113439
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive